Clinical Trial: Effect of Protein Hydrolysates on HbA1c Levels in Pre-diabetics

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional




Official Title: A Randomized, Double-blind, Placebo-controlled, Study to Assess Efficacy and Safety of 3 Different Daily Doses of Pea and Rice Protein Hydrolysates in the Reduction and Maintenance of HbA1c Levels in

Brief Summary:

To evaluate the effectiveness of three different daily doses of pea or rice protein hydrolysates versus placebo, when consumed over a 12-week period, at reducing and maintaining glycated haemoglobin (HbA1c) levels in a pre-diabetic population (otherwise healthy subjects with impaired glucose metabolism).

To evaluate the effectiveness of three different daily doses of pea or rice protein hydrolysates versus placebo, when consumed over a 12-week period on: post-prandial glucose/insulin levels (oral glucose tolerance test, fructosamine levels, fasting plasma glucose levels, vital signs, physical examinations, weight and blood pressure.